Gonadal axis hormones in psychiatric male patients after a suicide attempt

European Archives of Psychiatry and Clinical Neuroscience

Volumn 257, Issue 3, 2007, Pages 135-139

  Tripodianakis, John ^a   Markianos, Manolis ^b   Rouvali, Olga ^a   Istikoglou, Christos ^c  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Asclepeion Hospital   (Greece)

Author keywords

Attempted suicide; FSH; LH; Psychiatric diagnosis; Testosterone

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; FOLLITROPIN; LUTEINIZING HORMONE; NEUROLEPTIC AGENT; SEX HORMONE; TESTOSTERONE;

ADULT; AGGRESSION; ARTICLE; CONTROLLED STUDY; DRUG OVERDOSE; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCHIZOPHRENIA; STRESS; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; VIOLENCE;

ADULT; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HUMANS; LUTEINIZING HORMONE; MALE; MENTAL DISORDERS; OVERDOSE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE, ATTEMPTED; TESTOSTERONE; VIOLENCE;

EID: 34247115247     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0686-y     Document Type: Article

References (25)

1. Litman R (1967) Sigmund Freud on suicide. In: Shneidman E (ed) Essays in self-destruction. Science House, New York, pp 324-344
2. Lester D (1968) Suicide as an aggressive act. J Gen Psychol 79:83-86
3. Miotto P, De Coppi M, Frezza M, Petretto D, Masala C, Petri A (2003) Suicidal ideation and aggressiveness in school-aged youths. Psychiatry Res 120:247-255
4. Horesh N, Gothelf D, Ofek H, Weizman T, Apter A (1999) Impulsivity as a correlate of suicidal behavior in adolescent psychiatric inpatients. Crisis 20:8-14
5. Schneider B, Wetterling T, Sargk D, Schneider F, Schnabel A, Maurer K, Fritze J (2006) Axis I disorders and personality disorders as risk factors for suicide. Eur Arch Psychiatry Clin Neurosci 256:17-27
6. Engstrom G, Persson B, Levander S (1999) Temperament traits in male suicide attempters and violent offenders. Eur Psychiatry 14:278-283
7. Kalin NH (1999) Primate models to understand human aggression. J Clin Psychiatry 60(Suppl 15):S29-S32
8. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, et al. (1994) CSF biochemistries, glucose metabolism and diurnal activity rhythms in alcoholic violent offenders, fire setters and healthy volunteers. Arch Gen Psychiatry 51:20-27
9. Brooks JH, Reddon JR (1996) Serum testosterone in violent and nonviolent young offenders. J Clin Psychol 52:475-483
10. Banks T, Dabbs JM (1996) Salivary testosterone and cortisol in a delinquent and violent urban subculture. J Soc Psychol 136:49-56
11. Higley JD, Mehlman PT, Poland RE, Taub DM, Vickers J, Suomi SJ, et al. (1996) CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biol Psychiatry 40:1067-1082
12. Simon NG, Cologer-Clifford A, Lu SF, McKenna SE, Hu S (1998) Testosterone and its metabolites modulate 5HT1A and 5HT1B agonist effects on intermale aggression. Neurosci Behav Rev 23:325-336
13. Stefulj J, Buttner A, Kubat M, Zill P, Balija M, Eisenmenger W, Bondy B, Jernej B (2004) 5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations. Eur Arch Psychiatry Clin Neurosci 254:224-227
14. Evans J, Reeves B, Platt H, Leibenau A, Goldman D, Jefferson K, Nutt D (2000) Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH). Psychol Med 30:1327-1334
15. Butterfield MI, Stechuchac KM, Connor KM, Davidson JRT, Wang C, Mackuen CL, et al. (2005) Neuroactive steroids and suicidality in posttraumatic stress disorder. Am J Psychiatry 162:380-382
16. Thiblin I, Runeson B, Rajs J (1999) Anabolic androgenic steroids and suicide. Ann Clin Psychiatry 11:223-231
17. Gustavsson G, Traskman-Benz L, Higley JD, Westrin A (2003) CSF testosterone in 43 male suicide attempters. Eur Neuropsychopharmacol 13:105-109
18. Beck AT, Beck R, Kovacks M (1975) Classification of suicidal behaviors. I Quantifying intent and lethality. Am J Psychiatry 132:182-187
19. Markianos M, Hatzimanolis J, Lykouras L (1999) Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients. Eur Neuropsychopharmacol 9:533-536
20. Zitzmann M, Nieschlag E (2001) Testosterone levels in healthy men and the relation to behavioral and physical characteristics: facts and constructs. Eur J Endocrinol 144:183-197
21. Elman I, Breier A (1997) Effects of acute metabolic stress on plasma progesterone and testosterone in male subjects: relationship to pituitary-adrenocortical axis activation. Life Sci 61:1705-1712
22. Spratt DJ, Cox P, Orav J, Moloney J, Bigos T (1993) Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab 76:1548-1554
23. Brown AS, Hembree WC, Friedman JH, Kaufmann CA, Gorman JM (1995) The gonadal axis in men with schizophrenia. Psychiatry Res 28:231-239
24. Kaneda Y, Kavamura I, Fugii A, Ohmori T (2004) Impact of switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia. Neuroendocrinol Lett 25:135-140
25. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP (2006) Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 9:465-474